LGCmain
Indian Journal of Pathology and Microbiology
Home About us Instructions Submission Subscribe Advertise Contact e-Alerts Ahead Of Print Login 
Users Online: 2980
Print this page  Email this page Bookmark this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

ORIGINAL ARTICLE

The expression of immunohistochemical markers estrogen receptor, progesterone receptor, Her-2-neu, p53 and Ki-67 in epithelial ovarian tumors and its correlation with clinicopathologic variables

Sylvia Mary T, Kumar Surendra, Dasari Papa

Year : 2012| Volume: 55| Issue : 1 | Page no: 33-37

   This article has been cited by
 
1 Clinicopathological study of epithelial neoplasms of ovary with special reference to the expression of P53 and Her2/neu in epithelial carcinoma
Sarmila Sen, Amrita Chatterjee
Indian Journal of Pathology and Oncology. 2022; 9(1): 52
[Pubmed]  [Google Scholar] [DOI]
2 A cross-sectional study of immunohistochemical evaluation of surface epithelial ovarian tumors
Vikas Pandey, Jyotirmayee Mishra, PralhadS Potdar
MGM Journal of Medical Sciences. 2022; 9(1): 84
[Pubmed]  [Google Scholar] [DOI]
3 A Study of Expression and Significance of p53 in Malignant Ovarian Surface Epithelial Tumours
Ranjitha Vodigenahalli Nagaraj, Suchitha Satish
Indian Journal of Gynecologic Oncology. 2021; 19(2)
[Pubmed]  [Google Scholar] [DOI]
4 A Study of CD44 Positive Cancer Cells in Epithelial Ovarian Cancer and their Correlation with P53 And Ki67
Ketaki Kar, Suman Ghosh, Anup Kumar Roy
Journal of Laboratory Physicians. 2021; 13(01): 050
[Pubmed]  [Google Scholar] [DOI]
5 Immunohistochemical expression of HER - 2 and Ki - 67 in granulosa cell tumor in bitches
Ana Carina Heil da Silva Matos, Angélica Consalter, Bárbara Paula Santos Batista, Ana Beatriz Monteiro Fonseca, Ana Maria Reis Ferreira, Juliana da Silva Leite
Reproduction in Domestic Animals. 2021; 56(4): 667
[Pubmed]  [Google Scholar] [DOI]
6 STUDY OF THE IMMUNOHISTOCHEMICAL EXPRESSION OF p53 AND Ki67 (MIB1) IN OVARIAN TUMOURS AND THEIR CORRELATION WITH CLINICOPATHOLOGICAL FACTORS
Mita Nayak, Anita Choudhury, Debi Prasad Mishra
Journal of Evidence Based Medicine and Healthcare. 2019; 6(32): 2164
[Pubmed]  [Google Scholar] [DOI]
7 STUDY OF SURFACE EPITHELIAL OVARIAN MALIGNANCIES WITH REFERENCE TO THEIR HISTOLOGICAL GRADING AND ER & KI-67 IMMUNOREACTIVITY
Shalini Saurabh, Prasanna Kumar Satpathy
Journal of Evidence Based Medicine and Healthcare. 2019; 6(34): 2276
[Pubmed]  [Google Scholar] [DOI]
8 Estrogen receptor ß is associated with expression of cancer associated genes and survival in ovarian cancer
Susanne Schüler-Toprak,Florian Weber,Maciej Skrzypczak,Olaf Ortmann,Oliver Treeck
BMC Cancer. 2018; 18(1)
[Pubmed]  [Google Scholar] [DOI]
9 EVALUATION OF HER2/neu EXPRESSION IN OVARIAN EPITHELIAL TUMOURS
Arya P. R, Sheela Varghese, Sankar S
Journal of Evolution of Medical and Dental Sciences. 2018; 7(15): 1883
[Pubmed]  [Google Scholar] [DOI]
10 The Comparative Study of the Frequency of P53 and Ki67 Markers in Ovarian Epithelial Tumors and Their Relationship with Survival in Patients Presenting to Shahid Sadoughi Hospital of Yazd in 2013–2017
Shokouh Taghipour Zahir,Hedeye Nahangi,Koorosh Rahmani,Ezatollah Aalipour,Mohammad Baghi Yazdi
Indian Journal of Gynecologic Oncology. 2018; 16(2)
[Pubmed]  [Google Scholar] [DOI]
11 The association between reproductive and hormonal factors and ovarian cancer by estrogen-a and progesterone receptor status
Amy L. Shafrir,Megan S. Rice,Mamta Gupta,Kathryn L. Terry,Bernard A. Rosner,Rulla M. Tamimi,Jonathan L. Hecht,Shelley S. Tworoger
Gynecologic Oncology. 2016; 143(3): 628
[Pubmed]  [Google Scholar] [DOI]
12 The expression of HER-2/neu (c-erbB2), survivin and cycline D1 in serous ovarian neoplasms: their correlation with clinicopathological variables
Gulay Turan,Ceyda Sancakli Usta,Akin Usta,Mehmet Kanter,Lema Tavli,Meric Karacan,Cetin Celik,Metin Eser
Journal of Molecular Histology. 2014;
[Pubmed]  [Google Scholar] [DOI]
13 Significance of adhesion molecules expression for estimation of serous ovarian cancer prognosis
Ryabtseva, O.D., Lukianova, N.Y., Shmurakov, Y.A., Polishchuk, L.Z., Antipova, S.V.
Experimental Oncology. 2013; 35(3): 211-218
[Pubmed]  [Google Scholar]
14 Clinical implications and prognostic value of five biomarkers in endometrial carcinoma
Mingzhu Li,Lijun Zhao,Wenjuan Qi,Danhua Shen,Xiaoping Li,Jianliu Wang,Lihui Wei
The Chinese-German Journal of Clinical Oncology. 2013; 12(12): 586
[Pubmed]  [Google Scholar] [DOI]
15 IMPORTANCE OF MARKERS OF THE PROLIFERATION AND APOPTOSIS FOR OVARIAN BODERLINE TUMOURS
I I Vinogradov, L E Zavalishina, Yu Yu Andreeva, E V Akhidova, O M Volpina, T D Volkova, D O Koroev
I.P. Pavlov Russian Medical Biological Herald. 2013; 21(3): 130
[Pubmed]  [Google Scholar] [DOI]

 

Read this article